Reducing Skin Cancer Risk in Childhood Cancer Survivors

Summary

The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design.

Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.

Conditions

• Skin Neoplasms

Interventions

BEHAVIORAL

Patient activation and education (PAE)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface)

BEHAVIORAL

PAE plus physician activation (PAE + MD)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface), physician activation/educational materials about: (1) survivors' increased skin cancer risk; (2) the benefits of and the skills needed to conduct full-body skin exams; and (3) the importance of recommending routine SSE to patients

BEHAVIORAL

PAE physician activation, plus teledermoscopy (PAE +MD +TD)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface), physician activation/educational materials about: (1) survivors' increased skin cancer risk; (2) the benefits of and the skills needed to conduct full-body skin exams; and (3) the importance of recommending routine SSE to patients, and participant receipt of a dermoscopic lens

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• St. Jude Children's Research Hospital

  collaborator OTHER

• Dana-Farber Cancer Institute

  collaborator OTHER

• Memorial Sloan Kettering Cancer Center

  collaborator OTHER

• Emory University

  collaborator OTHER

• Harvard School of Public Health (HSPH)

  lead OTHER

Principal Investigators

• Alan Geller, RN, MPH · Harvard School of Public Health (HSPH)

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

30 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-03-31

Primary Completion

2018-01-01

Completion

2018-01-01

Countries

• United States

Study Locations